Recent Updates
Recently added Catalysts
CUVL Neutral Sentiment

Notice of initial substantial holder

Key Takeaway: The article provides a notice regarding the initial substantial holder for CLINUVEL Pharmaceuticals. It outlines various aspects of the company, including its governance, product offerings, and investor information. However, specific details about the substantial holder are not included in the text provided.
Price reaction · baseline $6.725 (2026-08-13 close) · hit pre-market · 1 other CUVL headline(s) in the window, move may be shared
day 0 close · peak
+2.6%

Market Sentiment Analysis

Full Press Release Details

• About About CLINUVEL People Corporate Governance Photomedicine Foundation Annual Reports
• Pharmaceuticals Pharmaceutical Development The Science Disease Entities Products
• PhotoCosmetics About PhotoCosmetics Polychromatic Photoprotection DNA Repair Melanogenesis
• Investors Investors Information ASX Announcements SEC Filings Analyst Coverage Media Coverage Company Snapshot Financial Summary Shareholder Information Investor Enquiry
• News
• Contact
• Store
• About CLINUVEL
• People
• Corporate Governance
• Photomedicine Foundation
• Annual Reports
• Pharmaceutical Development
• The Science
• Disease Entities
• Products
• About PhotoCosmetics
• Polychromatic Photoprotection
• DNA Repair
• Melanogenesis
• Investors Information
• ASX Announcements
• SEC Filings
• Analyst Coverage
• Media Coverage
• Company Snapshot
• Financial Summary
• Shareholder Information
• Investor Enquiry
Last updated: Aug 14, 2026